🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Severe Respiratory Exacerbation

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization NCT07587658Phase 41 site📍 Mullica Hill Regeneron Pharmaceuticals · Tests: dupilumab, Placebo 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation NCT07192016Phase 41 site📍 London Western University, Canada · Tests: fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg Respiratory Exacerbations in Children With Bronchopulmonary Dysplasia (BPD): A Case-Control Study NCT07666438n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA) NCT06705764Phase 42 sites📍 Edmonton📍 St. Albert University of Alberta · Tests: Tezepelumab, Placebo Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe). NCT06724315n/a1 site📍 São Paulo Hospital Israelita Albert Einstein Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis NCT07484607n/a6 sites📍 Cardiff📍 Exeter📍 Leeds Alexander Horsley Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations NCT07112456Phase 21 site📍 Muscat Oman Medical Speciality Board · Tests: Nebulized ketamine (0.5 mg/kg in normal saline to a total volume of 5ml) plus standard asthma excaerbationcare, Placebo… Withdrawal of Dupilumab in Severe Asthma NCT06818019Phase 429 sites📍 Toulouse📍 Amiens📍 Angers University Hospital, Toulouse · Tests: Stopping dupilumab Effect of IMT in Patients After Acute Exacerbations of COPD NCT07213128NA12 sites📍 Aalst📍 Anderlecht📍 Brussels KU Leuven · Tests: Training COPD Flare-Up Clinic After Severe Exacerbations NCT07629869NA1 site📍 Tel Aviv Tel-Aviv Sourasky Medical Center · Tests: Follow-up in a flare-up clinic Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial NCT05280132NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Personalized antibiotic treatment, Usual antibiotic treatment Multidisciplinary Management of Severe COPD NCT04860375NA1 site📍 Gothenburg Vastra Gotaland Region · Tests: Multidisciplinary patient care, Standard care Eosinopenia in Severe COPD Exacerbation NCT06188065n/a1 site📍 North Shields Northumbria Healthcare NHS Foundation Trust · Tests: Blood eosinophil count
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy